| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097496 Novel thiazine derivatives |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097483 Benzimidazole derivatives useful as histamine H3 antagonists |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
| 05/19/2004 | EP1419770A1 Apo ai expression accelerating agent |
| 05/19/2004 | EP1419165A1 Isoxazoline derivatives as p, n ligands |
| 05/19/2004 | EP1419152A1 Hiv inhibiting pyrimidines derivatives |
| 05/19/2004 | EP1418916A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer |
| 05/19/2004 | EP1418906A1 Aminoalkyl-substituted aromatic bicyclic compounds, method for the production thereof and their use as medicaments |
| 05/19/2004 | EP1263745B1 Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase |
| 05/19/2004 | EP1131308B1 New piperazine and piperidine compounds |
| 05/19/2004 | EP1086097B1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 05/19/2004 | EP0874629B1 ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS |
| 05/19/2004 | DE10251019A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 05/19/2004 | CN1498217A Heterocyclic compounds for aging-related and diabetic vascular complications |
| 05/19/2004 | CN1498213A Arylisoxazoline derivaties, method for production and use there of as pesticides |
| 05/19/2004 | CN1498212A New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors |
| 05/19/2004 | CN1498210A MCH antagonists and their use in treatment of obesity |
| 05/19/2004 | CN1498205A Aryl and biaryl compounds having MCH modulatory activity |
| 05/19/2004 | CN1496983A Method for preparing oxazolidone amine |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1150192C Piperidines as CCR5 modulators |
| 05/19/2004 | CN1150185C Propanolamine derivs. substd. with heteocyclic compound, methods for their production, pharmaceutical compositiions contg. said compounds and use thereof |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150166C CB2 receptor agonist compounds |
| 05/18/2004 | US6737431 Benzoxazole derivatives as novel melatonergic agents |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/18/2004 | US6737422 Voltage-dependent |
| 05/18/2004 | CA2334317C Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 05/13/2004 | WO2004039784A1 Novel phenylethanolamine derivatives and the use of the same as beta-3-agonists |
| 05/13/2004 | WO2004039762A1 Phenethanolamine derivatives for the treatment of respiratory diseases |
| 05/13/2004 | WO2004039365A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | WO2004029066A8 Bifunctional heterocyclic compounds and methods of making and using same |
| 05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
| 05/13/2004 | WO2004013101A3 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 05/13/2004 | WO2002055013A8 Therapeutic chromone compounds |
| 05/13/2004 | US20040092746 Fungicides |
| 05/13/2004 | US20040092604 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092569 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders |
| 05/13/2004 | US20040092554 4-piperidinyl alkyl amine derivatives as muscarinic receptor antagonists |
| 05/13/2004 | US20040092538 Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives |
| 05/13/2004 | US20040092535 Anticancer agents; antidiabetic agents; Alzheimer's disease; autoimmune disease |
| 05/13/2004 | US20040092524 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same |
| 05/13/2004 | US20040092521 Antihistamines; central nervous system disorders |
| 05/13/2004 | US20040092517 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 05/13/2004 | US20040092512 Central nervous system disorders; Parkinson's disease; Huntington's diseases; antidepressants; anxiolytic agents |
| 05/13/2004 | US20040092501 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 05/13/2004 | US20040092497 Heteroarylakanoic acids as intergrin receptor antagonists |
| 05/13/2004 | US20040092402 Pyrimidine derivatives and herbicides containing the same |
| 05/13/2004 | US20040088802 Produce powerful, particularly chromatic and bright colorations, in red tones, and which are relatively unselective and are stable to outside factors |
| 05/13/2004 | DE10251170A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/13/2004 | DE10240818A1 Substituierte 2-Pyrrolidin-2-yl-[1,3,4]-oxadiazol-Derivate Substituted 2-pyrrolidin-2-yl- [1,3,4] oxadiazol-derivatives |
| 05/13/2004 | CA2504511A1 Agent for preventing or treating neuropathy |
| 05/13/2004 | CA2504213A1 New beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/12/2004 | EP1418175A1 Respiratory syncytial virus replication inhibitors |
| 05/12/2004 | EP1417206A1 NOVEL 2 i H /i -PYRIDAZINE-3-ONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND A PROCESS FOR THE PREPARATION OF THE ACTIVE INGREDIENT |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417204A1 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
| 05/12/2004 | EP1417200A2 Substituted 1h-dihydropyrazoles, their preparation and use |
| 05/12/2004 | EP1417196A1 Dna-pk inhibitors |
| 05/12/2004 | EP1417190A1 Substituted piperazines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1417186A2 Heterocyclic aryl sulphonamides |
| 05/12/2004 | EP1417176A1 Substituted anthranilamides for controlling invertebrate pests |
| 05/12/2004 | EP1417175A1 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates, their preparation and use |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416931A1 Inhibitors of polyq-aggregation |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1416797A1 Arthropodicidal anthranilamides |
| 05/12/2004 | EP1416796A1 Method for controlling particular insect pests by applying anthranilamide compounds |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 05/12/2004 | EP1063235B1 Benzofurylpyrone derivatives |
| 05/12/2004 | EP1036065B1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | EP0960105B1 Benzofurazan compounds that enhance ampa receptor activity |
| 05/12/2004 | EP0927192B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 05/12/2004 | CN1496365A Herbicidal heterocyclic compound |
| 05/12/2004 | CN1496364A Substituted quinazoline derivatives and their use as inhibitors |
| 05/12/2004 | CN1496362A Non-imidazole compounds as histamine H3 antagonists |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1495181A Method for preparing cyclic oxazolidone containing sulfur and fluorine |
| 05/12/2004 | CN1495175A Halogenated pyrimidine and its application for reducing parasite |
| 05/12/2004 | CN1495174A Preparation method of isoxazolylalkyldione compound |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495170A Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 05/12/2004 | CN1495160A I-substituted-1-aminomethyl-cycloalkane derivative (gabapentin analogs), its preparation and application for curing neuropathy |
| 05/12/2004 | CN1495158A Intermediate for preparing isoxazolinyl-3-acylbenzene and process for preparing said intermediate |
| 05/12/2004 | CN1149213C Substituted benzoylisoxazoles and the use thereof as herbicides |
| 05/12/2004 | CN1149211C Benzoyl derivatives, method for producing them and their use as herbicids and plant growth regulators |
| 05/12/2004 | CN1149210C Thrombin inhibitors |
| 05/12/2004 | CN1149209C Triazole compounds with dopamine-D3-receptor affinity |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |